Role of Weight Loss Induced Prediabetes Remission in the Prevention of Type 2 Diabetes - Time to Improve Diabetes Prevention

Reiner Jumpertz von Schwartzenberg, Elsa Vazquez Arreola, Arvid Sandforth, Robert L Hanson, Andreas L Birkenfeld
{"title":"Role of Weight Loss Induced Prediabetes Remission in the Prevention of Type 2 Diabetes - Time to Improve Diabetes Prevention","authors":"Reiner Jumpertz von Schwartzenberg, Elsa Vazquez Arreola, Arvid Sandforth, Robert L Hanson, Andreas L Birkenfeld","doi":"10.1101/2024.03.22.24304576","DOIUrl":null,"url":null,"abstract":"Aims/hypothesis: For individuals with prediabetes, the current American Diabetes Association (ADA) guidelines recommend a body weight loss >7% to prevent the development of type 2 diabetes (T2D) without any glycemic target goals. However, we have recently shown that weight loss induced prediabetes remission reduces relative T2D risk by 73% within the following two years. Therefore, we investigated relative T2D risk reduction in people with weight loss vs those with weight loss and prediabetes remission in an independent cohort: the randomized controlled Diabetes Prevention Program (DPP). Methods: Individuals who lost >7% of their body weight over the first year were included in this analysis. Of these, 416 were assigned to intensive lifestyle intervention and 64 received placebo. Remission of prediabetes was defined by normalization of fasting and 2h glucose during an oral glucose tolerance test and a normalized HbA1c according to ADA criteria. Non-remission was given when at least one of these criteria was not met. We computed Kaplan-Meier curves and compared them using log-rank tests and future T2D risk was assessed by computing the relative risk between groups.\nResults: In DPP, 480 individuals achieved a weight loss of >7% and of these 114 additionally achieved prediabetes remission. Over the period of 6 years, those who achieved weight loss and remission had a 66% lower relative risk to develop T2D compared to those who only met the 7% weight loss goal [RR=0.34, 95% CI (0.15, 0.76)]. Similarly, weight loss responders had a lower relative future T2D risk compared to weight loss non-responders [RR=0.28, 95% CI (0.13, 0.64)]. Importantly, there was not a single T2D case in weight loss responders for up to 4 years after the intervention.\nConclusions/interpretation: The combination of achieving weight loss goals and prediabetes remission is most effective in reducing future T2D risk. Thus, beside weight loss goals, interventions in individuals with prediabetes should be continued until prediabetes remission is achieved and this ought to be adapted in current clinical praxis guidelines.","PeriodicalId":501419,"journal":{"name":"medRxiv - Endocrinology","volume":"65 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.03.22.24304576","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aims/hypothesis: For individuals with prediabetes, the current American Diabetes Association (ADA) guidelines recommend a body weight loss >7% to prevent the development of type 2 diabetes (T2D) without any glycemic target goals. However, we have recently shown that weight loss induced prediabetes remission reduces relative T2D risk by 73% within the following two years. Therefore, we investigated relative T2D risk reduction in people with weight loss vs those with weight loss and prediabetes remission in an independent cohort: the randomized controlled Diabetes Prevention Program (DPP). Methods: Individuals who lost >7% of their body weight over the first year were included in this analysis. Of these, 416 were assigned to intensive lifestyle intervention and 64 received placebo. Remission of prediabetes was defined by normalization of fasting and 2h glucose during an oral glucose tolerance test and a normalized HbA1c according to ADA criteria. Non-remission was given when at least one of these criteria was not met. We computed Kaplan-Meier curves and compared them using log-rank tests and future T2D risk was assessed by computing the relative risk between groups. Results: In DPP, 480 individuals achieved a weight loss of >7% and of these 114 additionally achieved prediabetes remission. Over the period of 6 years, those who achieved weight loss and remission had a 66% lower relative risk to develop T2D compared to those who only met the 7% weight loss goal [RR=0.34, 95% CI (0.15, 0.76)]. Similarly, weight loss responders had a lower relative future T2D risk compared to weight loss non-responders [RR=0.28, 95% CI (0.13, 0.64)]. Importantly, there was not a single T2D case in weight loss responders for up to 4 years after the intervention. Conclusions/interpretation: The combination of achieving weight loss goals and prediabetes remission is most effective in reducing future T2D risk. Thus, beside weight loss goals, interventions in individuals with prediabetes should be continued until prediabetes remission is achieved and this ought to be adapted in current clinical praxis guidelines.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
减肥诱导糖尿病前期缓解在预防 2 型糖尿病中的作用 - 是时候改进糖尿病预防了
目的/假设:对于糖尿病前期患者,美国糖尿病协会(ADA)现行指南建议体重减轻 7%,以预防 2 型糖尿病(T2D)的发生,但没有设定任何血糖目标。然而,我们最近的研究表明,体重减轻引起的糖尿病前期缓解可在随后两年内将相对 T2D 风险降低 73%。因此,我们在一个独立的队列:随机对照糖尿病预防计划(DPP)中,研究了体重减轻者与体重减轻且糖尿病前期缓解者的相对 T2D 风险降低情况。研究方法分析对象包括在第一年内体重减轻 7% 的人。其中,416 人被分配接受强化生活方式干预,64 人接受安慰剂治疗。根据美国糖尿病协会的标准,糖尿病前期缓解的定义是在口服葡萄糖耐量试验中空腹血糖和 2 小时血糖恢复正常,HbA1c 恢复正常。如果至少有一项标准未达到,则为未缓解。我们计算了卡普兰-梅耶曲线,并使用对数秩检验对其进行比较,通过计算组间相对风险来评估未来患 T2D 的风险:在 DPP 中,480 人的体重减轻了 7%,其中 114 人的糖尿病前期症状得到缓解。在6年的时间里,与仅达到减重7%目标的人相比,达到减重和缓解目标的人患T2D的相对风险降低了66%[RR=0.34, 95% CI (0.15, 0.76)]。同样,与体重减轻未达标者相比,体重减轻达标者未来患 T2D 的相对风险较低 [RR=0.28, 95% CI (0.13, 0.64)]。重要的是,在干预后长达 4 年的时间里,体重减轻应答者中没有出现一例 T2D 病例:结论/解释:实现减重目标与糖尿病前期缓解相结合,能最有效地降低未来患 T2D 的风险。因此,除了减肥目标外,还应继续对糖尿病前期患者进行干预,直到糖尿病前期症状得到缓解,这一点应被纳入当前的临床实践指南中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Free fatty acids accelerate β-cell death in type 1 diabetes Detection of enterovirus RNA in pancreas and lymphoid tissues of organ donors with type 1 diabetes Sex and age differences in cardiovascular risk factors and lifestyle at the onset of diabetes mellitus: a cross-sectional study in Spanish Primary Health Care. Establishing a Core Outcome Set for Creatine Transporter Deficiency and Guanidinoacetate Methyltransferase Deficiency Primary aldosteronism results in a decline estimated glomerular filtration rate independent of blood pressure: evidence from a case-control and mendelian randomization study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1